Table 3.
Baseline | Week 96 | |||
---|---|---|---|---|
Estimate (95% CI) | P | Estimate (95% CI) | P | |
SAT density, HU | −26.1 (−44.9 to −7.3) | 0.008 | −63.7 (−115.3 to −12.1) | 0.02 |
SAT area, cm2a | −0.9 (−2.5 to 0.7) | 0.26 | −0.3 (−2.6 to 2.0) | 0.80 |
Age, y | −7.8 (−20.9 to 5.3) | 0.24 | −0.8 (−28.0 to 26.4) | 0.95 |
Race or ethnicity | ||||
Black | −43.6 (−395.6 to 308.5) | 0.80 | 23.3 (−830.1 to 876.7) | 0.95 |
Hispanic white | 27.5 (−342.6 to 397.6) | 0.88 | 129.1 (−630.3 to 888.5) | 0.72 |
Other | −93.4 (−551.7 to 365.0) | 0.68 | −90.1 (−1073.8 to 893.5) | 0.85 |
Female sex at birth | 26.6 (−451.5 to 504.6) | 0.91 | 91.2 (−1194.5 to 1376.8) | 0.88 |
CD4+ T lymphocyte count, cells per mm3 | 0.8 (−0.1 to 1.7) | 0.08 | 0.4 (−1.9 to 2.7) | 0.72 |
HIV-1 RNA, log10 copies per mL | −37.9 (−285.7 to 210.1) | 0.76 | N/Ab | N/Ab |
Abbreviation: N/A, not applicable.
Area at baseline or week 96, respectively.
HIV-1 RNA <50 copies per milliliter for all participants at week 96.